Global Cosmetic Bioactive Ingredients Market (2022 to 2028) – Increase in Male-Centric Products Presents Opportunities – QNT Press Release

[ad_1]

DUBLIN, Sept. 20, 2022 /PRNewswire/ — The “Global Cosmetic Bioactive Ingredients Market 2022-2028” report has been added to ResearchAndMarkets.com’s offering.

The global cosmetic bioactive ingredients market is anticipated to witness growth at a CAGR of 5.84% during the forecast period 2022-2028.

Factors such as rising demand for personal care products, coupled with launch companies introducing new bioactive ingredients, are fueling the market’s growth. Additionally, the rise in male-centric products, the evolution of the cosmetic industry, and the launch of new products are expected to open new opportunities for the cosmetic bioactive ingredients market.

On the contrary, the side effects of personal care products and the harmful impact of cosmetic ingredients on the environment are expected to hamper the studied market’s growth globally.

Regional Outlook

The global cosmetic bioactive ingredients market encompasses North America, Asia-Pacific, Latin America, Europeand the Middle East and Africa regions.

Globally, the Asia-Pacific is expected to witness the fastest growth during the forecast period. This growth can be attributed to changes in lifestyle and rising demand for skincare products. Korean beauty products, for instance, have gained significant traction among the millennials and Gen-Z. This is mainly on account of growing social media trends pertaining to skin, hair, nails, etc. This has encouraged beauty companies to introduce new products containing bioactive ingredients to gain a competitive edge. Thus, these factors are expected to drive the cosmetic bioactive ingredients market.

Competitive Outlook

The prominent players operating in the market are Croda International, Clariant, Lubrizol, Ashland Global Holdings Inc, Symrise, Nouryon, BASF SE, Dow Chemical Company, Givaudan Active, Momentive Performance Materials, Zschimmer & Schwarz, Solvay, Provital, Evonik, and Gattefosse .

Full story available on Benzinga.com

[ad_2]

Source link